INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18330, 'Ginkonoro plus 30 capsules', 'جينكونورو بلس 30 كبسولة', '260', '240', 'Multivitamins', 'Citicoline 300 mg+ginkgo biloba 50 mg+magnesium+vitamin b6+vitamin b1', 'Egy minds', 'Capsule', 'كبسولة', '', '3', '', '', '', '', 2522, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18331, 'Enrich syrup 100 ml', 'انريتش شراب 100 مل', '34', '21.75', 'Anemia.iron supplement', 'Ferric hydroxide polymaltose', 'Marcyrl co.', 'Syrup', 'شراب', '100 ml', '1', '', '', '6223003579630', '', 2432, '2024-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03AB04', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18332, 'Aaa', 'ششش', '22', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 743, '2023-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18333, 'Skynor 20 cap', 'سكاينور 20 كبسولة', '150', '', 'Multivitamins', 'Ferrous bisglycinate 150mg+lactoferrin 100 mg+vit c 110 mg+folic acid 400mg+vit b1+vit b6+vit b12+vit e+molybdenum', 'Eveno pharm', 'Cap', 'كبسولة', '', '2', '', '', '', '', 674, '2023-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18335, 'Entecavir 0.25mg/5ml oral soln. 210 ml', 'انتيكافير 0.25 مجم / 5 مل عن طريق الفم 210 مل', '450', '', 'Antiviral.nucleoside', 'Entecavir', 'Global napi pharmaceuticals > penta pharma-egypt', 'Sol', 'محلول', '0.25mg', '1', 'مضاد فيروسات -- لعلاج التهاب الكبد الوبائي المزمن من النوع B', 'about entecavir nucleoside analog reverse transcriptase inhibitor oral antiviral drug used in the treatment of hepatitis b infection. mechanism of action of entecavir by competing with the natural substrate deoxyguanosine triphosphate entecavir functional', '', '', 863, '2022-08-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18336, 'Entecavir 0.5 mg 10 tab', 'انتيكافير 0.5مجم 10 اقراص', '300', '', 'Antiviral.nucleoside', 'Entecavir', 'Penta pharma-egypt', 'Tab', 'أقراص', '0.5 mg', '1', 'مضاد فيروسات -- لعلاج التهاب الكبد الوبائي المزمن من النوع ب', '', '', '', 6618, '2023-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18337, 'Entecavir 1 mg 10 tab.', 'انتاكافير 1مجم 10 اقراص', '450', '', 'Antiviral.nucleoside', 'Entecavir', 'Penta pharma-egypt', 'Tab', 'أقراص', '1 mg', '1', 'يستخدم لعلاج التهاب الكبد الفيروسي B', 'about entecavir nucleoside analog reverse transcriptase inhibitor oral antiviral drug used in the treatment of hepatitis b infection. mechanism of action of entecavir by competing with the natural substrate deoxyguanosine triphosphate entecavir functional', '', '', 2420, '2022-08-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18338, 'Enterogermina 2 billion/5ml oral susp. 10 mini bottles', 'انتيروجيرمينا 2 بليون/5مل معلق فموي 10 زجاجات صغيرة الحجم', '180', '150', 'Antidiarrhoeal', 'Bacillus clausii spores', 'Sanofi', 'Susp', 'معلق', '5ml', '10', 'علاج الاسهال -- تنظيم حركة المعدة و الامعاء', 'what is enterogermina? enterogermina is a probiotic which is useful for the management of imbalance of intestinal bacterial flora due to diverse causes. enterogermina is used to effectively manage diarrhoea and for treating the alterations of the intestin', '3582910075455', '', 3648, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18339, 'Enterolok 10 f.c.tab.', 'انتيرولوك 10 اقراص', '19', '', 'Antibiotic quinolone with antiprotozoal', 'Norfloxacin+tinidazole', 'Hochster pharmaceutical industries', 'Tab', 'أقراص', '', '1', '', 'enterolok tablets is a combination of norfloxacin an anti microbial agent ( quinolone group ) and effective anti anerobic bactericidal agent (tinidazole). this combination shows a great efficacy and control against gastrointestinal infections due to susce', '', '', 1404, '2022-07-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18340, 'Enteromycin dry 60 ml syrup', 'انتيرومايسين شراب جاف 60 مل', '5', '', 'Antidiarrheal', 'Alumina gel+clioquinol+streptomycin', 'El nile.', 'Syrup', 'شراب', '60 ml', '1', 'علاج حمى الأرانب -- الحفاظ على صحة الجهاز الهضمي -- لعلاج الإسهال الناتج عن عدوى بكتيرية', '', '', '', 1144, '2023-04-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18341, 'Aaa', 'ششش', '8', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 740, '2023-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18342, 'Enteroquin comp. pd. for oral susp. 60 ml', 'انتروكين كومب باودر لعمل معلق 60 مل', '5', '', 'Antidiarrheal', 'Homatropine methylbromide+iodoquinol+kaolin+phthalyl sulphathiazole+sulphadimidine+vitamin b1+b6+b12', 'Arab drug company.', 'Susp', 'معلق', '60 ml', '1', '', '', '6221060000760', '', 998, '2023-05-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18343, 'Entocid 20*10 tab.', 'انتوسيد 20*10 قرص', '300', '127.5', 'Antidiarrheal', 'Diiodohydroxyquinoline+phthalylsulfathiazol+streptomycin', 'Cid', 'Tab', 'أقراص', '', '20', '', '', '6221043011035', '', 1175, '2024-11-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18345, 'Aaa', 'ششش', '12', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 654, '2022-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18346, 'Aaa', 'ششش', '5', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 772, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18347, 'Entophar 500 mg 5 vag. ovules', 'انتوفار 500 مجم 5 بويضات مهبلية', '9', '4.25', 'Antiprotozoal.nitroimidazole', 'Metronidazole', 'Pharopharma', 'Unknown', 'غير محدد', '500 mg', '1', '', 'about metronidazolesa nitroimidazole antibiotic anti-infective antiprotozoal amebicide.smechanism of action of metronidazolesmetronidazole is nitro imidazoles which have broad spectrum cidal activity against protozoa and some anaerobic bacteria. its selec', '6221094503169', '', 1091, '2025-08-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics.[L3754] It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections.[A181036,A181039] Metronidazole has been used as an antibiotic for several decades[L7429], with added antiparasitic properties that set it apart from many other antibacterial drugs, allowing it to treat a wide variety of infections. It is available in capsule form, tablet form, and topical form, and suppository preparations for the treatment of various infections.', '["A02BD11", "P01AB52", "D06BX01", "A02BD03", "J01XD01", "J01RA04", "A02BD01", "J01RA14", "A02BD15", "J01RA03", "A01AB17", "G01AF20", "J01RA10", "A02BD02", "A02BD13", "G01AF01", "P01AB51", "A02BD08", "P01AB01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18348, 'Entresto 100 mg (49/51 mg) 28 f.c. tabs.', 'انترستو 100مجم 28 قرص', '1,700', '1369', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '100 mg', '2', 'علاج ارتفاع ضغط الدم -- علاج الفشل القلبي', '', '300780777209', '01076134210066551727093010TJLU2 2110712547671476', 11757, '2024-09-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18349, 'Entresto 200 mg (97/103 mg) 56 f.c. tabs.', 'انترستو 200مجم 56 قرص', '3,559', '2738', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '200 mg', '4', 'علاج ارتفاع ضغط الدم', '', '300780696203', '', 4994, '2024-07-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18350, 'Entresto 50 mg (24/26 mg) 28 f.c. tabs.', 'انترستو 50مجم 28 قرص', '1,700', '1369', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '50 mg', '2', 'علاج ارتفاع ضغط الدم', '', '300780659208', '', 14571, '2024-07-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18351, 'Entyvio 300 mg vial for inf.', 'انتيفيو 300مجم فيال للاطفال', '48,824', '36600', 'Ulcerative colitis', 'Vedolizumab', 'Takeda > pharma overseas', 'Vial', 'فيال', '300 mg', '1', '', 'indications: entyvio (vedolizumab) is indicated for adult patients with moderately to severely active ulcerative colitis (uc) or crohns disease (cd) who have had an inadequate response with were intolerant to or demonstrated dependence on corticosteroids', '', '', 2617, '2024-07-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Vedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation. It is used in the treatment of moderate to severe active ulcerative colitis and Crohn''s disease for patients who have had an inadequate response with, lost response to, or were intolerant to inhibitors of tumor necrosis factor-alpha (TNF-alpha) or other conventional therapies. By blocking its primary target, α4β7 integrin, vedolizumab reduces inflammation in the gut. Vedolizumab is administered by IV infusion over a period of 30 minutes; after the first dose, it is given again at two and six weeks and then every 8 weeks thereafter.', '["L04AA33"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18352, 'Epanutin 100mg 50 caps', 'ايبانوتين 100مجم 50 كبسولة', '14', '', 'Anti-epileptic.hydantoin', 'Phenytoin', 'El nile. > pfizer', 'Cap', 'كبسولة', '100mg', '5', '', '', '', '', 3916, '2022-07-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Phenytoin is classified as a hydantoin derivative and despite its narrow therapeutic index, it is one of the most commonly used anticonvulsants.[A33595,A188832,A189219] Since it''s introduction about 80 years ago, phenytoin has not only been established as an effective anti-epileptic, but has also been investigated for several other indications such as bipolar disorder, retina protection, and wound healing.[A188826,A188832]

Clinicians are advised to initiate therapeutic drug monitoring in patients who require phenytoin since even small deviations from the recommended therapeutic range can lead to suboptimal treatment, or adverse effects.[A189219,A35884] Both parenteral and oral formulations of phenytoin are available on the market.[A189219]', '["N03AB02", "N03AB52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18353, 'Epcidin s.r. 6 mg 10 caps.', 'ابسيدين اس ار 6 مجم 10 كبسولات', '8', '', 'Cns.analgesic.skeletal muscle relaxant.alpha2 agonist', 'Tizanidine', 'Epci', 'Cap', 'كبسولة', '6 mg', '1', 'مسكن وباسط للعضلات ومضاد للالتهابات', 'about tizanidine a centrally acting a-2 adrenergic agonist centrally acting muscle relaxant (short-acting). mechanism of action of tizanidine this drug is a centrally acting alpha2 agonist at alpha2-adrenergic receptor sites and presumably reduces spastic', '', '', 1058, '2022-07-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tizanidine is a fast-acting drug used for the management of muscle spasm, which may result from the effects of multiple sclerosis, stroke, an acquired brain injury, or a spinal cord injury [T574].  It may also be caused by musculoskeletal injury [A177583].  Regardless of the cause, muscle spasticity can be an extremely painful and debilitating condition. 

Initially approved by the FDA in 1996, tizanidine is an Alpha-2 adrenergic receptor agonist reducing spasticity by the presynaptic inhibition of excitatory neurotransmitters that cause firing of neurons promoting muscle spasm [FDA label].', '["M03BX02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18355, 'Epcifam 20mg 10 orally disentigrating tabs.', 'ابسيفام 20 مجم 10 اقراص', '7', '', 'Peptic ulcer.anti-histamine.h2 antagonist', 'Famotidine', 'Epci', 'Tab', 'أقراص', '20mg', '1', '', 'about famotidine guanidine:thiazole derivative a histamine h2-receptor antagonist anti-secretory antiulcer. mechanism of action of famotidine famotidine is a h2 (histamine) receptor antagonist. histamine is the most potent stimulus of acid secretion and a', '', '', 946, '2022-07-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Famotidine is a competitive histamine-2 (H2) receptor antagonist that works to inhibit gastric acid secretion. It is commonly used in gastrointestinal conditions related to acid secretion, such as gastric ulcers and gastroesophageal reflux disease (GERD), in adults and children.[L11166] Compared to other H2receptor antagonists, famotidine displays high selectivity towards this receptor; in a study consisting of healthy volunteers and patients with acid hypersecretory disease, famotidine was about 20 to 50 times more potent at inhibiting gastric acid secretion than [cimetidine] and eight times more potent than [ranitidine] on a weight basis.[A189462] Famotidine is used in various over-the-counter and off-label uses.[L11166] While oral formulations of famotidine are more commonly used, the intravenous solution of the drug is available for use in hospital settings.[L11142]', '["A02BA03", "A02BA53"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18356, 'Epcifam plus 10 chewable tab.', 'ابسيفام بلس 10 اقراص مضغ', '7', '', 'Antacid', 'Aluminium hydroxide+famotidine+magnesium hydroxide', 'Epci', 'Tab', 'أقراص', '', '1', '', 'about aluminium hydroxide antacid antidote protectant( topical) in hyperacidity; hyperphosphatemia. mechanism of action of aluminium hydroxide it neutralizes and reduces stomach acid relieving heartburn (acid reflux gerd) and indigestion. this results inc', '', '', 969, '2022-08-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18357, 'Epciflurifen 8.75 mg 20 lozenges', 'ابسيفلوريفين 8.75 مجم 20 قرص استحلاب', '14', '', 'Nsaid.propionic acid derivatives', 'Flurbiprofen', 'Epci', 'Lozenges', 'استحلاب', '8.75 mg', '2', '', 'about flurbiprofen nsaid oral phenylalkanoic acid derivative analgesic and anti-inflammatory anti arthritic. mechanism of action of flurbiprofen it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both cox1 and cox2.in higher doses it', '', '', 771, '2022-07-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.', '["M02AA19", "M01AE09", "R02AX01", "S01BC04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18358, 'Epcimox 125mg 8 oral dis. tab.', 'ابسيموكس 125 مجم 8 اقراص', '3', '', 'Penicillins.monocomponent', 'Amoxicillin', 'Epci', 'Tab', 'أقراص', '125mg', '1', '', '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '', '', 991, '2022-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18359, 'Epcimox 250mg 8 oral dis. tab.', 'ايبسيموكس 250 مجم 8 أقراص', '5', '', 'Penicillins.monocomponent', 'Amoxicillin', 'Epci', 'Tab', 'أقراص', '250mg', '1', '', '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '', '', 925, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18360, 'Epcura mr 4mg 10 tab.', 'ايبكيورا ام ار 4 مجم 10 قرص', '10', '', 'Antihypertensive.selective alpha 1 receptor blockers', 'Doxazosin', 'Epci', 'Tab', 'أقراص', '4mg', '1', '', 'about doxazosin alpha-1 adrenergic antagonist quinazoline derivative antihypertensive. mechanism of action of doxazosin the drug exerts its antihypertensive action by acting as a selective alpha-1 antagonist. it dilates both arteries and veins thus it red', '', '', 886, '2022-08-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661]  Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]', '["C02CA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18361, 'Ephedrine-cid 30mg/ml 100 amp.', 'افيديرين سيد 30 مجم/مل 100 امبولة', '700', '400', 'Sympathomimetic', 'Ephedrine', 'Cid', 'Amp', 'أمبول', '30mg', '100', 'علاج ارتفاع ضغط الدم -- موسع للشعب الهوائية -- علاج الازمات التنفسية و القلبية', '', '', '', 1200, '2024-11-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ephedrine was first described in western literature in 1888, as a naturally occurring component of the ephedra plant, along with [pseudoephedrine].[A193698] Ephedrine acts as both a direct and indirect sympathomimetic. It is an alpha- and beta-adrenergic receptor agonist; however, it also causes the indirect release of norepinephrine from sympathetic neurons, inhibiting norepinephrine reuptake and displacing more norepinephrine from storage vesicles.[A193650,L12972] Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects.[L12972] Ephedrine and [phenylephrine] are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists.[A193701,A193704,L12975] Ephedrine was granted a type 7 FDA Approval on 29 April 2016.[L12975]', '["S01FB02", "R01AB05", "C01CA26", "R03CA02", "A08AA56", "R01AA03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18362, 'Ephedrine sulphate-misr 25mg/ml 100 amp.', 'ايفيدرين سلفات 25 مجم / مل 100 امبول', '600', '400', 'Sympathomimetic', 'Ephedrine', 'Misr', 'Amp', 'أمبول', '25mg', '100', '', '', '', '', 2710, '2024-11-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ephedrine was first described in western literature in 1888, as a naturally occurring component of the ephedra plant, along with [pseudoephedrine].[A193698] Ephedrine acts as both a direct and indirect sympathomimetic. It is an alpha- and beta-adrenergic receptor agonist; however, it also causes the indirect release of norepinephrine from sympathetic neurons, inhibiting norepinephrine reuptake and displacing more norepinephrine from storage vesicles.[A193650,L12972] Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects.[L12972] Ephedrine and [phenylephrine] are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists.[A193701,A193704,L12975] Ephedrine was granted a type 7 FDA Approval on 29 April 2016.[L12975]', '["S01FB02", "R01AB05", "C01CA26", "R03CA02", "A08AA56", "R01AA03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18363, 'Aaa', 'ششش', '398', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 665, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18364, 'Epiao 10000i.u./ml vial', 'ابياو 10000 وحدة دولية/مل فيال', '210', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shenyang sunshine pharmaceutical co. > egyptian pharmex', 'Vial', 'فيال', '', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '', '', 729, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18365, 'Aaa', 'ششش', '53', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 629, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18366, 'Epiao 4000i.u./ml vial', 'ابياو 4000 وحدة دولية/مل فيال', '155', '118', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shenyang sunshine pharmaceutical co. > egyptian pharmex', 'Vial', 'فيال', '', '1', 'يستخدم لعلاج الأنميا الناتجة عن (عملية زرع الكلى أو بعض الأدوية اللي تستخدم في علاج مرض الإيدز).', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6909389581053', '', 4391, '2024-11-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18367, 'Epicare hand sanitizer topical solution 125 ml', 'ابيكير محلول موضعي مطهر لليدين 125 مل', '30', '', 'Antiseptic', 'Alcohol 80%', 'Eipico', 'Solution', 'محلول', '125 ml', '1', '', 'alcohol antiseptic non-sterile solution', '', '', 934, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18368, 'Aaa', 'ششش', '36', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 770, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18369, 'Epicephin 1gm i.v. vial', 'ابيسيفين 1جم فيال وريد', '60', '45', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '1gm', '1', '', '', '6221032312181', '', 1757, '2024-09-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18370, 'Epicephin 2gm i.v. vial', 'ابيسيفين 2 جم فيال وريد', '77', '55', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '2gm', '1', '', '', '6221032314109', '', 2858, '2024-08-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18371, 'Epicephin 250mg i.m. vial', 'ابيسيفين 250مجم فيال عضل', '22', '7', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '250mg', '1', '', '', '6221032319500', '', 789, '2024-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18372, 'Epicephin 250mg i.v. vial', 'ابيسيفين 250مجم فيال وريد', '22', '7', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '250mg', '1', '', '', '6221032318701', '', 918, '2024-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18373, 'Epicephin 500mg i.v. vial', 'ابيسيفين 500مجم فيال وريد', '47', '33', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '500mg', '1', '', '', '6221032335814', '', 1070, '2024-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18376, 'Epicocillin 125mg/5ml 100ml susp.', 'ابيكوسيللين 125مجم/5مل معلق 100 مل', '7', '', 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '125mg', '1', '', 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032150509', '', 958, '2023-01-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18377, 'Aaa', 'ششش', '5', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 769, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18378, 'Epicocillin 250mg 12 caps.', 'ابيكوسيللين 250مجم 12 كبسولة', '7', '', 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Cap', 'كبسولة', '250mg', '2', '', 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032130556', '', 887, '2023-01-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18379, 'Aaa', 'ششش', '4', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 677, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18380, 'Epicocillin 250mg/5ml 100ml susp.', 'ابيكوسيللين 250 مجم/5 مل معلق 100 مل', '9', '', 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '250mg', '1', '', 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032150707', '', 729, '2022-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18381, 'Epicocillin 250mg/5ml susp. 60 ml', 'ابيكوسيللين 250مجم/5مل معلق 60 مل', '7', '', 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '250mg', '1', '', '', '', '', 998, '2023-01-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18383, 'Aaa', 'ششش', '5', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 878, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18384, 'Epicoflocin 200 mg 10 f.c.tab.', 'ابيكوفلوسين 200 مجم 10 قرص', '28', '18', 'Antibiotic.quinolone', 'Ofloxacin', 'Eipico', 'Tab', 'أقراص', '200 mg', '1', 'مضاد حيوى واسع المدى يستخدم فى علاج العديد من الالتهابات', '', '6221032298997', '', 972, '2025-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.', '["J01MA01", "J01RA09", "S01AE01", "S02AA16"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18385, 'Aaa', 'ششش', '12', '', '', '', '', 'Unknown', 'غير محدد', '', '0', 'للحموضة', '', '', '', 794, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18386, 'Epicopentin 600mg 30 f.c. tab.', 'ابيكوبنتين 600 مجم 30 قرص', '138', '102', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Eipico', 'Tab', 'أقراص', '600mg', '3', '', '', '6221032101662', '', 2052, '2025-05-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid ([GABA]) that was first approved for use in the United States in 1993.[L8717] It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures[A186277,A186143] - today it is also widely used to treat neuropathic pain.[A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism making it unlikely to participate in pharmacokinetic drug interactions.[A186143,A185981,L8717]. It is structurally and functionally related to another GABA derivative, [pregabalin].', '["N03AX12"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18387, 'Epicopentin 800 mg 30 f.c. tabs.', 'ابيكوبنتين 800 مجم 30 اقراص', '110', '28', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Eipico', 'Tab', 'أقراص', '800 mg', '3', 'دواء مضاد للصرع ، ويسمى أيضًا مضاد الاختلاج. وهو يؤثر على المواد الكيميائية والأعصاب في الجسم التي تسبب التشنجات وبعض أنواع الألم', '', '6221032101679', '', 4304, '2024-11-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid ([GABA]) that was first approved for use in the United States in 1993.[L8717] It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures[A186277,A186143] - today it is also widely used to treat neuropathic pain.[A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism making it unlikely to participate in pharmacokinetic drug interactions.[A186143,A185981,L8717]. It is structurally and functionally related to another GABA derivative, [pregabalin].', '["N03AX12"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18390, 'Epicopred 20 mg 20 orodispersible tabs.', 'ابيكوبريد 20مجم 20 قرص ذائب بالفم', '104', '72', 'Glucocorticoid', 'Prednisolone', 'Eipico', 'Tab', 'أقراص', '20 mg', '2', 'مضاد التهاب كورتيزوني', 'about prednisolone systemic synthetic glucocorticoid immunosuppressant. mechanism of action of prednisolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid re', '6221032119667', '', 30769, '2024-08-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]

Prednisolone was granted FDA approval on 21 June 1955.[L9431]', '["D07AA03", "S01CA02", "D07XA02", "A01AC54", "R01AD02", "S01BB02", "R01AD52", "S01CB02", "V03AB05", "S03BA02", "D07BA01", "D07CA03", "S01BA04", "S02BA03", "A07EA01", "H02AB06", "S02CA01", "C05AA04", "S03CA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18391, 'Epicopred 5 mg 30 orodispersible tabs.', 'ابيكوبريد 5مجم 30 قرص', '69', '48', 'Glucocorticoid', 'Prednisolone', 'Eipico', 'Tab', 'أقراص', '5 mg', '3', 'مضاد عام للالتهابات والحساسية', 'about prednisolone systemic synthetic glucocorticoid immunosuppressant. mechanism of action of prednisolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid re', '6221032119551', '', 33486, '2024-08-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]

Prednisolone was granted FDA approval on 21 June 1955.[L9431]', '["D07AA03", "S01CA02", "D07XA02", "A01AC54", "R01AD02", "S01BB02", "R01AD52", "S01CB02", "V03AB05", "S03BA02", "D07BA01", "D07CA03", "S01BA04", "S02BA03", "A07EA01", "H02AB06", "S02CA01", "C05AA04", "S03CA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18392, 'Aaa', 'ششش', '21', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 610, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18393, 'Aaa', 'ششش', '14', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 858, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18394, 'Epicotil 20mg i.m./i.v. 3 vial', 'ابيكوتيل 20مجم 3 فيال', '48', '28.5', 'Nsaid.oxicam', 'Tenoxicam', 'Eipico', 'Vial', 'فيال', '20mg', '3', '', 'mechanism of action of tenoxicam the anti-inflammatory effects of tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors their inhi', '6221032311115', '', 3552, '2024-12-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AC02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18397, 'Epident tooth paste 50 gm', 'ابيدنت معجون اسنان 50 جم', '5', '', 'Oral care', 'Salvadora persica powder(miswak)+veltol plus+propylene glycol+sodium phosphate(monobasic & di-basic)', 'Eipico', 'Unknown', 'غير محدد', '50 gm', '1', '', '-kills harmful germs -protect from tooth decay -strengthens the gum', '6221032242211', '', 785, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18398, 'Epi-derm silicone gel sheet 14.5*12 cm', 'ابيدرم لزقة سيليكون جيل 14.5 سم * 12 سم', '923', '', 'Scar therapy', '', 'Biodermis corp. > united health care', 'Gel', 'جل', '', '1', 'لزقة لازالة ومعالجة الندبات', '100% silicone sheet for scars', '', '', 1029, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18399, 'Epiderm soothing cream 50 gm', 'ابيدرم كريم ملطف 50 جرام', '70', '55', 'Soothing topical', 'Panthenol+olive oil+chamomile+zinc oxide+petrolatum+sunflower oil+glycerin+beeswax', 'Egyptian company for cosmetics > kmt pharma', 'Cream', 'كريم', '50 gm', '1', 'كريم ملطف للجلد', 'skin soothing cream.', '6224011031097', '', 10822, '2024-05-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18400, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 675, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18402, 'Aaa', 'ششش', '23', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 737, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18403, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 656, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18405, 'Aaa', 'ششش', '9', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 763, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18406, 'Epifenac 100mg 5 rectal supp.', 'ابيفيناك 100 مجم 5 اقماع', '21', '13.5', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '100mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117779', '', 877, '2025-05-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18407, 'Epifenac 100mg s.r. 10 caps.', 'ابيفيناك 100 مجم اس ار 10 كبسولات', '33', '22', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Cap', 'كبسولة', '100mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117779', '', 1418, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18408, 'Epifenac 12.5mg 5 supp.', 'ابيفيناك 12.5 مجم 5 اقماع', '15', '9', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '12.5mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250346', '', 1127, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18409, 'Aaa', 'ششش', '12', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 745, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18410, 'Epifenac 25mg 5 supp.', 'ابيفيناك 25 مجم 5 اقماع', '15', '9', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '25mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250322', '', 874, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18411, 'Epifenac 50 mg 5 supp.', 'ابيفيناك 50 مجم 5 اقماع', '9', '', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '50 mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250902', '', 923, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18412, 'Aaa', 'ششش', '14', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 688, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18413, 'Epifenac 75mg s.r. 10 tabs.', 'ابيفيناك 75 مجم اس ار 10 اقراص', '29', '19', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Tab', 'أقراص', '75mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117786', '', 1142, '2025-02-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18414, 'Aaa', 'ششش', '18', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 809, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18415, 'Aaa', 'ششش', '145', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 727, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18416, 'Epigent 20mg/2ml i.v./i.m. 3 amp.', 'ابيجينت 20مجم/2مل 3 امبولات', '24', '10.5', 'Aminoglycoside antibiotic', 'Gentamicin', 'Eipico', 'Amp', 'أمبول', '20mg', '3', '', '', '6221032320469', '', 919, '2024-12-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364]

Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]', '["S01AA11", "S02AA14", "D06AX07", "S03AA06", "J01GB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18417, 'epigent 80mg/2ml i.m./i.v. 3 amps.', 'ابيجينت 80مجم/2مل 3 امبولات', '54', '15', 'Aminoglycoside antibiotic', 'gentamicin', 'eipico', 'ampoule', 'أمبول', '80mg', '3', '', 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6221032320506', '', 1685, '2025-12-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364]

Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]', '["S01AA11", "S02AA14", "D06AX07", "S03AA06", "J01GB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18418, 'Epigonal 75 i.u. 1 amp.', 'ابيجونال 75 وحدة دولية 1 امبول', '286', '200', 'Infertility drugs.human menopausal gonadotrophin', 'Human menopausal gonadotrophin (fsh+lh)', 'Eipico', 'Amp', 'أمبول', '', '1', 'يساعد في حالات تأخر الانجاب في الرجال والسيدات -- يساعد علي انتاج الحيوانات المنوية -- تحفيز انتاج البويضات', 'description menotropins contains follicle stimulating hormone (fsh) and luteinizing hormone (lh) purified from the urine of postmenopausal women. it is used as a fertility medication that is injected either subcutaneously or intramuscularl mechanism of ac', '6221032323002', '', 16898, '2024-07-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G03GA02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18419, 'Epikavit 10mg 10 chew. tabs.', 'ابيكافيت 10 مجم 10 اقراص', '5', '', 'Vitamin k', 'Vitamin k1', 'Eipico', 'Tab', 'أقراص', '10mg', '1', '', 'about vitamin k fat soluble vitamin antihemorrhagic. mechanism of action of vitamin k phytonadione (vitamin k1) is a synthetic form of vitamin k and is lipid soluble. vitamin k acts as a cofactor in the synthesis of coagulation proteins; prothrombin facto', '', '', 790, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18421, 'Aaa', 'ششش', '7', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 640, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18422, 'Aaa', 'ششش', '4', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 638, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18423, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 618, '2022-10-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18425, 'Epilog 250mg/5ml 10 amp. for i.v. inj.', 'ابيلوج 250 مجم / 5 مل 10 امبول', '50', '30', 'Anti-epileptic.hydantoin', 'Phenytoin', 'Mup', 'Inj', 'حقن', '250mg', '10', 'يستخدم في علاج الصرع حيث يعمل العلاج على إبطاء السيالات العصبية و منع تكون نوبات الصرع أو السيطرة عليها', 'about phenytoin hydantoin derivative anticonvulsant class ib antiarrhythmic agent. mechanism of action of phenytoin phenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. it prolongs the inac', '', '', 1708, '2024-12-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Phenytoin is classified as a hydantoin derivative and despite its narrow therapeutic index, it is one of the most commonly used anticonvulsants.[A33595,A188832,A189219] Since it''s introduction about 80 years ago, phenytoin has not only been established as an effective anti-epileptic, but has also been investigated for several other indications such as bipolar disorder, retina protection, and wound healing.[A188826,A188832]

Clinicians are advised to initiate therapeutic drug monitoring in patients who require phenytoin since even small deviations from the recommended therapeutic range can lead to suboptimal treatment, or adverse effects.[A189219,A35884] Both parenteral and oral formulations of phenytoin are available on the market.[A189219]', '["N03AB02", "N03AB52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18427, 'Epimate 100mg 10 caps.', 'ابيمات 100مجم 10 كبسولات', '14', '', 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '100mg', '1', 'علاج التشنجات.', 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', '', '', 879, '2022-05-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18428, 'Epimate 200 mg 10 caps.', 'ابيمات 200 مجم 10 كبسولات', '24', '', 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '200 mg', '1', '', 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', '', '', 766, '2022-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18429, 'Epimate 25 mg 10 caps.', 'ابيمات 25 مجم 10 كبسولات', '10', '', 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '25 mg', '1', '', 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', '', '', 886, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18430, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 678, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18431, 'Epimazepine cr 200 mg 10 controlled release f.c. tabs.', 'ابيمازيبين سي ار 200 مجم 10 اقراص', '6', '', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Eipico', 'Tab', 'أقراص', '200 mg', '1', 'علاج حالات الصرع مثل بعض حالات نوبات الصرع الجزئية الصرع الكبير.اضطراب النوبة.الصرع الذي يظهر فيه أكتر من نوع واحد من أنواع النوبات.', 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', '', '', 3183, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]', '["N03AF01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18432, 'Epimazepine cr 400 mg 10 controlled release f.c. tabs.', 'ابيمازيبين سي ار 400 مجم 10 اقراص', '10', '', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Eipico', 'Tab', 'أقراص', '400 mg', '1', '', 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', '', '', 1097, '2022-07-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]', '["N03AF01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18433, 'Epimiraflu 75 mg 10 caps.', 'ابيميرافلو 75مجم 10 كبسولات', '202', '140', 'Anti-viral.release phase', 'Oseltamivir', 'Eipico', 'Cap', 'كبسولة', '75 mg', '1', 'مضاد للفيروسات', 'about oseltamivir antiviral neuraminidase inhibitor mechanism of action of oseltamivir oseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to active form oseltamivir carboxylate. oseltamivir is a neuraminidase inhibitor serving', '6221032131775', '', 6831, '2025-11-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Oseltamivir (marketed as the product TamifluⓇ), is an antiviral neuraminidase inhibitor used for the treatment and prophylaxis of infection with influenza viruses A (including pandemic H1N1) and B. Oseltamivir exerts its antiviral activity by inhibiting the activity of the viral neuraminidase enzyme found on the surface of the virus, which prevents budding from the host cell, viral replication, and infectivity.

The clinical benefit of use of oseltamivir is greatest when administered within 48 hours of the onset of influenza symptoms since effectiveness decreases significantly after that point in time; there is generally no benefit in use beyond 48 hours for healthy, low-risk individuals as influenza is a self-limiting illness.[A180574, L7267, A180580] However, antiviral treatment might be beneficial when initiated after 48 hours for patients with severe, complicated or progressive illness or for hospitalized patients.[A180583] According to the CDC, data from clinical trials and observational studies have demonstrated that early antiviral treatment can shorten the duration of fever and illness symptoms, and may reduce the risk of some complications (including pneumonia and respiratory failure). They recommend the use of oseltamivir in people with a higher risk of developing complications including children younger than 2 years, people over 65 years, people with some chronic conditions or immunosuppression, pregnant women, residents of long term care facilities, and indigenous communities for example.[L7264]

The benefits of oseltamivir use are controversial; a 2014 Cochrane Review of the evidence found that oseltamivir treatment had limited benefit. The authors concluded that oseltamivir use in healthy adults had small, non-specific effects on symptoms (where the time to first alleviation of symptoms was only reduced from 7 to 6.3 days), it had no effect on hospitalizations, and that there was no evidence for any reductions in complications of influenza such as pneumonia.[A179962, A179965, A179968] Due to the risk of adverse effects such as nausea, vomiting, psychiatric effects and renal adverse events in adults and vomiting in children, the harms are generally considered to outweigh the small clinical benefit of use of oseltamivir. 

Notably, in 2017, the World Health Organization downgraded oseltamivir from its essential medicines list from a "core" drug to a "complementary" drug, due to limited cost-effectiveness.[A179086] Yearly vaccination with the influenza vaccine is still considered the best preventative measure.', '["J05AH02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18434, 'Aaa', 'ششش', '88', '67', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 853, '2023-08-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18435, 'Epinephrine-memphis 1 mg/ml 5 i.m./s.c. amp.', 'ابينفرين ممفيس 1مجم /مل 5 امبولات', '10', '', 'Alpha and beta adrenergic agonist', 'Adrenaline', 'Memphis', 'Amp', 'أمبول', '1 mg', '5', 'علاج حالات الحساسية المفرطة', 'about adrenaline alpha and beta adrenergic agonist catecholamine vasoconstrictor. anti asthma inanaphylatic shock. mechanism of action of adrenaline adrenaline is an alpha and beta adrenergic agonist which exerts it`s therapeutic actions through predomina', '', '', 1228, '2023-05-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18436, 'Epinephrine-misr 1 mg/ml 100 amp.', 'ابينفرين - مصر 1مجم/مل 100 امبولة', '750', '600', 'Alpha and beta adrenergic agonist', 'Adrenaline', 'Misr', 'Amp', 'أمبول', '1 mg', '100', '', 'about adrenaline alpha and beta adrenergic agonist catecholamine vasoconstrictor. anti asthma inanaphylatic shock. mechanism of action of adrenaline adrenaline is an alpha and beta adrenergic agonist which exerts it`s therapeutic actions through predomina', '', '', 1484, '2024-12-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18438, 'Epinos fruit 6 eff. salt sachet', 'ايبينوس فواكه 6 اكياس فوار', '4', '', 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', '', '1', '', 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', '', '', 1010, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18439, 'Epinos pineapple 6 eff. salt 6sachet', 'ابينوس اناناس 6 اكياس فوار', '4', '', 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', '', '1', '', 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', '', '', 808, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18440, 'Epinos pineapple 60 eff. salt sachet', 'ابينوس اناناس 60 اكياس فوار', '18', '', 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', '', '1', '', 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', '', '', 1066, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18442, 'Epiphenicol 1% eye oint. 5 gm', 'ابيفينيكول 1% مرهم للعين 5 جم', '7', '', 'Antibiotic', 'Chloramphenicol', 'Eipico', 'Oint', 'مرهم', '1%', '1', '', 'description an antibiotic first isolated from cultures of streptomyces venequelae in 1947 but now produced synthetically. it has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. it acts by interfering with bacter', '', '', 919, '2022-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An antibiotic first isolated from cultures of _Streptomyces venequelae_ in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)

The FDA has withdrawn all oral drug products containing chloramphenicol, due to the high risk of fatal aplastic anemia associated with this specific route of administration.[L43942,L44022]', '["D06AX02", "S02AA01", "D10AF03", "S01AA01", "G01AA05", "J01BA01", "S03AA08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18443, 'Epiquantel 600mg 4 f.c. tabs.', 'ابيكوانتيل 600 مجم 4 اقراص', '32', '16.5', 'Anthelmintic', 'Praziquantel', 'Eipico', 'Tab', 'أقراص', '600mg', '1', '', 'about praziquantel anthelmintic a trematodicide. mechanism of action of praziquantel it is a broad spectrum anthelminthic against trematodes & cestodes and their larval forms. the drug exerts its action by producing strong muscular contractions which lead', '6221032115683', '', 1799, '2025-04-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthelmintic used in most schistosome and many cestode infestations.', '["P02BA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18444, 'Carla extra 30 tabs.', 'كارلا اكسترا 30 قرص', '125', '98', 'Calcium', 'Calcium+magnesum+vitamin d3+zinc', 'Pharmazad>renovo', 'Tab', 'أقراص', '', '1', 'مكمل غذائى لدعم النمو الطبيعى للعظام والوقاية من الكساح وهشاشة العظام وتخفيف الشد العضلى', '', '795697032808', '', 4431, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18445, 'Update body oil 60 ml', 'ابديت زيت للجسم 60 مل', '225', '80', '', 'Bergamot oil', 'Abs pharma', 'Oil', 'زيت', '60 ml', '1', '', '', '', '', 3441, '2024-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18447, 'Aaa', 'ششش', '44', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 805, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18448, 'Epirelefan 40mg/ml i.m amp.', 'ابيريليفان 40مجم فيال', '38', '26', 'Anti-inflammatory.glucocorticoid.', 'Triamcinolone acetonide', 'Eipico', 'Amp', 'أمبول', '40mg', '1', 'مضاد للالتهابات ومخفف للالام', 'about triamcinolone acetonide a synthetic glucocorticoid topical anti-inflammatory(steroidal). mechanism of action of triamcinolone acetonide the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes', '6221032318305', '', 6447, '2024-09-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18449, 'Aaa', 'ششش', '16', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 725, '2022-10-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18450, 'Dexamethasone-inad 8mg/2ml 3amp', 'ديكساميثازون ايناد 8مجم/2مل 3 امبولات', '36', '22.5', '', 'Dexamethasone phosphate', 'Inad pharma', 'Amp', 'أمبول', '8mg', '3', '', '', '', '', 1940, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724]

Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]', '["R01AD53", "D07XB05", "R01AD03", "D10AA03", "S01CB01", "S02CA06", "S03CA01", "C05AA09", "S01CA01", "D07CB04", "H02AB02", "S01BA01", "A01AC02", "S03BA01", "D07AB19", "S02BA06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18451, 'Epirovastin 10 mg 14 scored f.c. tab', 'ابيروفاستين 10مجم 14 قرص', '56', '21', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Eipico', 'Tab', 'أقراص', '10 mg', '2', 'دواء خافض لدهون الدم والكوليسترول الضار', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6221032119896', '', 3787, '2024-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18452, 'Epirovastin 20 mg 14 f.c. tab', 'ابيروفاستين 20مجم 14 قرص', '76', '28.5', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Eipico', 'Tab', 'أقراص', '20 mg', '2', 'دواء خافض لدهون الدم', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6221032107664', '', 3556, '2024-11-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18453, 'Aaa', 'ششش', '80', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 711, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18454, 'Epirubicin (ebewe) 50mg/25ml vial', 'ايبريوبسين ابيوي 50مجم/25مل مل فيال', '740', '300', 'Antineoplastic', 'Epirubicin', 'Sandoz > b.p pharma', 'Vial', 'فيال', '50mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 792, '2025-01-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18455, 'Epirubicin (ebewe) 10mg/5ml vial', 'ابيوريسين 2مجم/مل 10مجم فيال', '221', '80', 'Antineoplastic', 'Epirubicin', 'Sandoz > b.p pharma', 'Vial', 'فيال', '10mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 813, '2025-01-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18457, 'Epirubicin mylan 100mg/50ml vial i.v. inf.', 'ايبريوبسين ميلان 100مجم/50مل مل فيال', '643', '', 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '100mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 830, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18458, 'Epirubicin mylan 10mg/5ml vial i.v. inf.', 'ايبريوبسين ميلان 10مجم/5مل مل فيال', '85', '', 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '10mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 860, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18459, 'Epirubicin mylan 200mg/100ml vial i.v. inf.', 'ايبريوبسين ميلان 200مجم/100مل مل فيال', '1,260', '', 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '200mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 850, '2022-07-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18460, 'Aaa', 'ششش', '378', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 712, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18462, 'Episovir 400mg 28 f.c. tablets', 'ابيسوفير 400 مجم 28 قرص', '900', '', 'Antiviral', 'Sofosbuvir', 'Eipico', 'Tablet', 'أقراص', '400mg', '4', '', 'indications and usage: it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. *efficacy has been establish', '', '', 744, '2022-07-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Sofosbuvir (tradename Sovaldi) is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Treatment options for chronic Hepatitis C have advanced significantly since 2011, with the development of Direct Acting Antivirals (DAAs) such as sofosbuvir. As a prodrug nucleotide analog, Sofosbuvir is metabolized into its active form as the antiviral agent 2''-deoxy-2''-α-fluoro-β-C-methyluridine-5''-triphosphate (also known as GS-461203), which acts as a defective substrate for NS5B (non-structural protein 5B) [synthesis]. NS5B, an RNA-dependent RNA polymerase, is essential for the transcription of Hepatitis C viral RNA and for its high replicative rate and genetic diversity [A19594]. Sofosbuvir and other direct acting antivirals are therefore very potent options for the treatment of Hepatitis C, as they exhibit a high barrier to the development of resistance [A19593]. This is an important advantage relative to HCV drugs that target other viral enzymes such as the protease, for which rapid development of resistance has proven to be an important cause of therapeutic failure.  

In a joint recommendation published in 2016, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) recommend Sofosbuvir as first line therapy in combination with other antivirals for all six genotypes of Hepatitis C [L852]. Depending on the genotype, sofosbuvir is often used in combination with other antivirals such as [DB09027], [DB11613], [DB09102], [DB06290], [DB11574], [DB11575], [DB00811], [DB00008], or [DB00022] with the intent to cure, or achieve a sustained virologic response (SVR), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. Treatment with direct acting antivirals such as sofosbuvir is associated with very minimal side effects, with the most common being headache and fatigue [FDA Label]. Lack of significant side effects and short duration of therapy is a considerable advantage over older interferon- and ribavirin-based regimens, which were limited by infusion site reactions, reduced blood count, and neuropsychiatric effects [A19635]. 

Since 2014, sofosbuvir has been available as a fixed dose combination product with [DB09027] (tradename Harvoni) used for the treatment of chronic Hepatitis C. Approved in October 2014 by the FDA, Harvoni is indicated for the treatment of HCV genotypes 1, 4, 5, and 6 with or without [DB00811] depending on the level of liver damage or cirrhosis [FDA Label].  When combined together, ledipasvir and sofosbuvir as the combination product Harvoni has been shown to achieve a SVR between 93 and 99% after 12 weeks of treatment [A7535]. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV [A19627].

Sofosbuvir is also available as a fixed dose combination product with [DB11613] as the commercially available product Epclusa. First approved in June 2016, Epclusa is the first combination HCV product indicated for the treatment of all genotypes of Hepatitis C with or without cirrhosis. Epclusa is also currently the most potent HCV antiviral medication on the market with a sustained virologic response (SVR) after 12 weeks of therapy of 93-99% depending on genotype and level of cirrhosis [L852]. Both Canadian and American guidelines list Epclusa as a first line recommendation for all genotypes of HCV [L852, A19626].

Notably, sofosbuvir has come under intense scrutiny since its release to market in 2013. With the price per pill set at $1000, a 12-week treatment can cost upwards of $84,000 per patient [A19636].', '["J05AP08", "J05AP51", "J05AP55", "J05AP56"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18463, 'Aaa', 'ششش', '10', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 762, '2022-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18464, 'Epistigmin 2.5mg/ml vial', 'ابيستجمين 2.5مجم/مل فيال', '42', '18', 'Para-sympathomimetic', 'Neostigmine', 'Eipico', 'Vial', 'فيال', '2.5mg', '1', 'علاج الوهن العضلي', '', '6221032316615', '', 1076, '2024-11-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier.', '["N07AA01", "S01EB06", "N07AA51"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18465, 'Epitaxol 0.5% eye drops 5 ml', 'ابيتاكسول 0.5% قطرة 5 مل', '19', '13.2', 'Antihypertensive.beta blocker.selective b1', 'Betaxolol', 'Eipico', 'Drops', 'نقط', '0.5%', '1', '', 'about betaxolol cardioselective beta 1-adrenergic blocker anti glaucoma antihypertensive. mechanism of action of betaxolol betaxolol is a selective beta 1 (? 1) blocker. it inhibits the beta receptors present in the eye such as in the ciliary body epithel', '6221032331908', '', 1025, '2025-05-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.', '["S01ED02", "C07AB05", "S01ED52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18466, 'Epitens 30 tab.', 'ابيتينس 30 قرص', '7', '', 'Antihypertensive', 'Triamterene+xipamide', 'Eipico', 'Tab', 'أقراص', '', '3', 'علاج ارتفاع ضغط الدم', '', '6221032112446', '', 1357, '2023-01-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'C03BA10', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18468, 'Epival 10 mg 20 tabs.', 'ابيفال 10 مجم 20 قرص', '11', '', 'Anti-epileptic.benzodiazepines', 'Diazepam', 'Eipico', 'Tab', 'أقراص', '10 mg', '2', '', 'about diazepam a benzodiazepine derivative with cns depressant anxiolytic anticonvulsant hypnotic sedative skeletal muscle relaxant and amnestic. mechanism of action of diazepam diazepam mainly acts on limbic system and ascending reticular formation in th', '', '', 819, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)

Given diazepam''s storied history as a commonly used and effective medication for a variety of indications, contemporary advancements in the formulation and administration of the agent include the development and US FDA approval of an auto-injectable formulation for the rapid treatment of uncontrolled seizures in 2015-2016 [L5200]. Combining diazepam, a proven effective therapy for acute repetitive seizures, with an auto-injector designed for subcutaneous administration that is quickly and easily administered offers the potential for complete, consistent drug absorption and rapid onset of effect [L5200]. This current development is subsequently an important addition to the rescue therapy tool chest for patients with epilepsy [L5200].', '["N05BA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18469, 'Epival 10mg/2ml 3 amp.', 'ابيفال 10 مجم /2مل 3 امبولات', '15', '5', 'Anti-epileptic.benzodiazepines', 'Diazepam', 'Eipico', 'Amp', 'أمبول', '10mg', '6', 'علاج حالات الصرع -- تقليل للتشنجات المصاحبة للصرع', 'about diazepam a benzodiazepine derivative with cns depressant anxiolytic anticonvulsant hypnotic sedative skeletal muscle relaxant and amnestic. mechanism of action of diazepam diazepam mainly acts on limbic system and ascending reticular formation in th', '', '', 1279, '2024-11-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)

Given diazepam''s storied history as a commonly used and effective medication for a variety of indications, contemporary advancements in the formulation and administration of the agent include the development and US FDA approval of an auto-injectable formulation for the rapid treatment of uncontrolled seizures in 2015-2016 [L5200]. Combining diazepam, a proven effective therapy for acute repetitive seizures, with an auto-injector designed for subcutaneous administration that is quickly and easily administered offers the potential for complete, consistent drug absorption and rapid onset of effect [L5200]. This current development is subsequently an important addition to the rescue therapy tool chest for patients with epilepsy [L5200].', '["N05BA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18470, 'Epivel cream 80 gm', 'ابيفيل كريم 80 جم', '80', '', 'Moisturizing topicals', 'Shea butter+jojoba oil+wheat germ oil+aloe vera+carrot seed oil+castor seed oil+apricot oil+xanthan gum', 'Nikim co. > al watania co. herbs-food-cosmetics', 'Cream', 'كريم', '80 gm', '1', 'كريم مرطب', 'emollient cream', '', '', 1375, '2022-05-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18471, 'Epizin 10mg vial for i.v. inj./inf.', 'ابيزين 10 مجم فيال', '75', '', 'Antineoplastic', 'Epirubicin', 'Korea united pharma > eimc', 'Inj', 'حقن', '10mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 794, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18472, 'Epizin 50mg vial for i.v. inf.', 'ابيزين 50 مجم فيال وريد', '300', '', 'Antineoplastic', 'Epirubicin', 'Korea united pharma > eimc', 'Vial', 'فيال', '50mg', '1', '', 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', '', '', 743, '2022-07-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18473, 'Epizithro 200mg/5ml 15ml susp.', 'ابيزيثرو 200 مجم/5 مل 15 مل', '47', '32.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Susp', 'معلق', '200mg', '1', 'مضاد حيوى واسع المدى يستخدم فى علاج العديد من الالتهابات', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032162014', '', 1178, '2025-04-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18474, 'Epizithro 200mg/5ml 30ml susp.', 'ابيزيثرو 200 مجم/5 مل 30 مل', '68', '47.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Susp', 'معلق', '200mg', '1', 'مضاد حيوى واسع المدى يستخدم لعلاج العديد من الالتهابات', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032162007', '', 4131, '2025-04-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18475, 'Epizithro 500 mg 3 caps.', 'ابيزيثرو 500 مجم 3 كبسولات', '62', '43.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Cap', 'كبسولة', '500 mg', '1', 'مضاد حيوي', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032137876', '', 11780, '2025-07-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18476, 'Epizolone-depot 40mg/ml 1 ml i.m. vial', 'ابيزولون-ديبوت 40مجم/مل 1 مل فيال', '39', '27', 'Glucocorticoid', 'Methylprednisolone', 'Eipico', 'Vial', 'فيال', '40mg', '1', '', 'indication adjunctive therapy for short-term administration in rheumatoid arthritis. mechanism of action unbound glucocorticoids cross cell membranes and bind with high affinity to specific cytoplasmic receptors modifying transcription and protein synthes', '6221032311276', '', 2621, '2025-05-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Methylprednisolone is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone].[A188811] It was first described in the literature in the late 1950s.[A188811,A188814]

Methylprednisolone was granted FDA approval on 24 October 1957.[L10785] In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression.[A192813] The efficacy of methylprednisolone in novel coronavirus pneumonia is being investigated further in clinical trials.[L12666]', '["D10AA02", "H02AB04", "H02BX01", "D07CA02", "S01CA08", "D07AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18477, 'Eplorefix 25 mg 7 f.c. tab', 'ايبلورفيكس 25مجم 7 اقراص', '22', '', 'Aldosterone receptor antagonist', 'Eplerenone', 'Hikma pharma', 'Tab', 'أقراص', '25 mg', '1', '', '', '', '', 846, '2022-06-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18478, 'Eplorefix 50mg 7 f.c. tab.', 'ايبلورفيكس 50مجم 7 قرص', '27', '', 'Aldosterone receptor antagonist', 'Eplerenone', 'Hikma pharma', 'Tab', 'أقراص', '50mg', '1', '', 'description eplerenone an aldosterone receptor antagonist similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', '', '', 1004, '2022-07-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18479, 'Epoetin sedico 2000 i.u./ml vial.', 'ايبوتين سيديكو 2000 وحدة دولية / مل فيال', '84', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Sedico', 'Vial', 'فيال', '', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '', '', 910, '2023-04-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18480, 'Epoetin sedico 4000 i.u./ml vial.', 'ايبوتين سيديكو 4000 وحدة دولية / مل فيال', '196', '149.5', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Sedico', 'Vial', 'فيال', '', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6221042550016', '', 10780, '2024-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18481, 'Epoform 2000 i.u vial', 'ايبوفورم 2000 وحدة دولية فيال', '60', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Eipico', 'Vial', 'فيال', '', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6221032321183', '', 725, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18482, 'Egunaz d3 oral drops 10 ml', 'ايجوناز د3 نقط للفم 10 مل', '65', '', 'Dietary supplement', 'Vitamin d3', 'Core pharm', 'Drops', 'نقط', '10 ml', '1', '', '', '', '', 891, '2023-05-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18483, 'Epojet 10000 i.u./ml prefilled syringe', 'ايبوجيت 10000 وحدة دولية/مل سرنجة معبأة للحقن', '275', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Vacsera > multipharma', 'Syringe', 'حقنة', '', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '', '', 824, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18484, 'Epojet 2000 i.u./0.5ml prefilled syringe', 'ايبوجيت 2000وحدة دولية/0.5مل سرنجة معبأة للحقن', '60', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Vacsera > multipharma', 'Syringe', 'حقنة', '0.5ml', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '', '', 619, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18485, 'Azotec mix massage spray 200 ml', 'ازوتك مكس مساج سبراي 200 مل', '350', '290', 'Massage spray', 'Tocopherol (vit e)+laurocapram+menthol+eucalyptus globulus leaf (eucalyptus)+eugenia caryophyllus flower extract (clove)+allantoin+magnesium sulfate+(camphora oil)+panax ginseng root extract+persea gratissima oil (avocado oil)+butyrospermum parkii butter (shea butter)+glyceryl stearate+arctium lappa root extract+carbomer+phenoxyethanol+10-hydroxystearic acid+triethanolamine', 'Koncieve', 'Spray', 'بخاخ', '200 ml', '1', '', '', '', '', 1861, '2025-12-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18486, 'Eposin 20mg/ml vial', 'ايبوسين 20 مجم / مل فيال', '40', '', 'Antineoplastic', 'Etoposide', 'Pharmachemie-netherlands > copad pharma', 'Vial', 'فيال', '20mg', '1', '', 'about etoposide derivative of podophyllotoxin antineoplastic agent. mechanism of action of etoposide this semi synthetic derivative of podophyllotoxin arrests cells in g2 phase. it stabilizes the dna cleavage normally catalysed by topoisomerase 2 and inhi', '', '', 739, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18487, 'Eposino 2000 i.u./1ml prefilled syringe', 'ايبوسينو 2000 وحدة دولية / 1 مل حقنة', '60', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shandong kexing bioproducts co. > united pharma international-egypt', 'Syringe', 'حقنة', '1ml', '1', '', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '', '', 784, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18488, 'Eposino 4000 i.u./ml prefilled syringe', 'ايبوسينو 4000وحدة دولية/مل سرنجة معبأة للحقن', '175', '98', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shandong kexing bioproducts co. > united pharma international-egypt', 'Syringe', 'حقنة', '', '1', 'علاج الانيميا', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6923564236989', '', 6388, '2024-03-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18489, 'Aaa', 'ششش', '60', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 650, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18490, 'Epotin julphar 4000 i.u/1ml s.c/i.v. vial', 'ايبوتين جلفار 4000 وحدة دولية/مل فيال', '115', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Julphar', 'Vial', 'فيال', '1ml', '1', '', '', '6221042550405', '', 1118, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18491, 'Aaa', 'ششش', '4,896', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 762, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18492, 'Vavra d3 10 000 iu 30 caps', 'فافرا دي 3 10000 وحدة دولية 30 كبسولة', '150', '126', 'vitamin d3', 'Cholecalciferol', 'Trendy for manufacturing specialised nutrition and dietary supplements', 'Cap', 'كبسولة', '000 iu', '3', '', '', '', '', 740, '2025-01-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight [L5689]. Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake [L5689]. Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 [L5689]. Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use [L5689].

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism [A223, L5689, L1782, L5771, F4027, F4042, F4048]. However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency [L5689].', '["M05BB09", "M05BX53", "M05BB07", "M05BB08", "A11CC55", "M05BB05", "A11CC05", "M05BB03", "M05BB04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18493, 'Eprex 3000 i.u./0.3ml 6 prefilled syringe', 'ايبريكس 3000 وحدة دولية/0.3مل 6 سرنجات معبأة', '1,470', '', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Janssen cilag > soficopharm', 'Syringe', 'حقنة', '0.3ml', '6', '', '', '', '', 938, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18494, 'Eprex 4000 i.u./0.4ml 6 prefilled syringes', 'ابريكس 4000 وحدة دولية/0.4مل 6 سرنجات معبأة', '2,793', '1995', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Janssen cilag > soficopharm', 'Syringe', 'حقنة', '0.4ml', '6', 'علاج فقر الدم و انخفاض عدد كرات الدم الحمراء', '', '', '', 16236, '2023-12-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18495, 'Cefaxotrez 1 gm i.v. vial', 'سيفاكسوتريز 1 جم وريد فيال', '96', '66.5', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Boston care pharmaceuticals', 'Vial', 'فيال', '1 gm', '1', '', '', '', '', 756, '2024-10-28', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18496, 'Eraloner 25 mg 20 f.c.tab.', 'ايرالونير 25مجم 20 قرص', '136', '102', 'Aldosterone receptor antagonist', 'Eplerenone', 'Multi-apex', 'Tab', 'أقراص', '25 mg', '2', 'علاج ارتفاع ضغط الدم ( قد يستخدم وحده أو مع غيره من أدوية ارتفاع ضغط الدم) قُصُورُ القلْبِ الاحْتِقانِي الذي يحدث بعد احتشاء عضلة القلب.', 'description eplerenone an aldosterone receptor antagonist. similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', '6223003205331', '', 10910, '2025-06-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18497, 'Eraloner 50 mg 20 f.c. tab.', 'ايرالونير 50مجم 20 قرص', '198', '149', 'Aldosterone receptor antagonist', 'Eplerenone', 'Multi-apex', 'Tab', 'أقراص', '50 mg', '2', 'علاج ارتفاع ضغط الدم', 'description eplerenone an aldosterone receptor antagonist similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', '6223003205355', '', 2577, '2025-06-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18498, 'Erastapex 20 mg 30 f.c.tab.', 'ايراستابكس 20مجم 30 قرص', '75', '52.5', 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Multi-apex', 'Tab', 'أقراص', '20 mg', '3', '', 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', '6223003202729', '', 2305, '2024-10-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium, among others. Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 

Olmesartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] 

By comparison, the angiotensin-converting enzyme inhibitor (ACEi) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibit the conversion of angiotensin I to angiotensin II through inhibition of the ACE enzyme. However, this does not prevent the formation of all angiotensin II within the body. The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 

Olmesartan is commonly used for the management of hypertension and Type 2 Diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] 

Orally available olmesartan is produced as the prodrug olmesartan medoxomil which is rapidly converted _in vivo_ to the pharmacologically active olmesartan.[A175330] It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L12882]', '["C09DA08", "C09DX03", "C09CA08", "C09DB02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18499, 'Freemove 30 tabs.', 'فري موف 30 قرص', '690', '590', 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Glucosamine+chondroitin+msm+collagen+ginko biloba+copper+manganese+vitamin c+vitamin d3', 'Maddox pharma', 'Tab', 'أقراص', '', '3', '', '', '', '', 1208, '2025-06-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18500, 'Erastapex 5 mg 30 f.c.tab. (n/a)', 'ايراستابكس 5مجم 30 قرص', '18', '', 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Multi-apex', 'Tab', 'أقراص', '5 mg', '3', '', 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', '', '', 923, '2023-06-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium, among others. Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 

Olmesartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] 

By comparison, the angiotensin-converting enzyme inhibitor (ACEi) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibit the conversion of angiotensin I to angiotensin II through inhibition of the ACE enzyme. However, this does not prevent the formation of all angiotensin II within the body. The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 

Olmesartan is commonly used for the management of hypertension and Type 2 Diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] 

Orally available olmesartan is produced as the prodrug olmesartan medoxomil which is rapidly converted _in vivo_ to the pharmacologically active olmesartan.[A175330] It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L12882]', '["C09DA08", "C09DX03", "C09CA08", "C09DB02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18501, 'Aaa', 'ششش', '90', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 714, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18502, 'nan 3 milk 400 gm', 'نان 3 لبن اطفال 400 جم', '360', '350', 'Milk products.third stage (age 1-3 years)', 'milk formula stage 3', 'nestle', 'piece', 'غير محدد', '400 gm', '1', '', 'not to replace mother s milk. for children from age 1 year and onward. to be used within 3 weeks from opening.', '7613033358555', '', 994, '2026-01-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18504, 'Letracitolin120ml syrup', 'ليتراسيتولين 120 مل شراب', '120', '', 'Support brain function', 'Citicoline', 'Medicolena', 'Syrup', 'شراب', '120ml', '1', '', '', '', '', 1084, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N06BX06', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18507, 'Erastapex trio 5/40/12.5mg 30 f.c. tabs', 'ايراستابكس تريو 5/40/12.5مجم 30 قرص', '144', '108', 'Antihypertensive.combined angiotensin blocker & ca++ channel blocker & diuretic', 'Amlodipine+olmesartan+hydrochlorothiazide', 'Multi-apex', 'Tab', 'أقراص', '12.5mg', '3', 'علاج ارتفاع ضغط الدم', '', '6223003206567', '', 5960, '2024-10-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18508, 'Erbitux 100mg/20ml vial', 'اربيتوكس 100مجم/20 مل فيال', '3,631', '3026', 'Antineoplastic', 'Cetuximab', 'Boehringer ingelheim > serono scientific office', 'Vial', 'فيال', '100mg', '1', '', 'cetuximab is an epidermal growth factor receptor (egfr) inhibitor used for the treatment of metastatic colorectal cancer metastatic non-small cell lung cancer and head and neck cancer. cetuximab is a chimeric (mouse/human) monoclonal antibody given by int', '', '', 1316, '2025-04-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor (EGF).[A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis.[A228083] EGFR has been implicated in various types of cancer, as it is often overexpressed in malignant cells [A227973] and EGFR overexpression has been linked to more advanced disease and poor prognosis.[A227963] EGFR is often mutated in certain types of cancer and serves as a driver of tumorigenesis.[A228083] _In vitro_, cetuximab was shown to mediate anti-tumour effects in numerous cancer cell lines and human tumour xenografts.[A227963]

Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic colorectal cancer with a BRAF V600E mutation.[A227963,L39045] It has also been investigated in advanced colorectal cancer, EGFR-expressing non-small cell lung cancer (NSCLC), and unresectable squamous cell skin cancer.[L31418] Cetuximab is administered via intravenous infusion and is used as monotherapy or in combination with other chemotherapies, including platinum agents, radiation therapy, [leucovorin], [fluorouracil], and [irinotecan].[L30448]', '["L01FE01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18509, 'Erdolytic 175mg pd. for oral susp. 100 ml', 'اردوليتيك 175 مجم / 5 مل معلق 100 مل', '27', '', 'Mucolytic', 'Erdosteine', 'Andalous pharma', 'Susp', 'معلق', '175mg', '1', '', '', '', '', 966, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18510, 'Erdolytic 300 mg 20 caps.', 'اردوليتيك 300مجم 20 كبسولة', '124', '61', 'Mucolytic', 'Erdosteine', 'Andalous pharma', 'Cap', 'كبسولة', '300 mg', '2', 'مذيب للبلغم -- يخفف من الكحة المصحوبة بالبلغم', 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', '6223004690037', '', 4342, '2024-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18511, 'Erdosolvine 300 mg 10 caps.', 'اردوسولفين 300 مجم 10 كبسولات', '69', '43', 'Mucolytic', 'Erdosteine', 'Borg', 'Cap', 'كبسولة', '300 mg', '1', 'مذيب بلغم', 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', '6223002570935', '', 4206, '2024-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18512, 'Erdotinol 300mg 10 caps.', 'اردوتينول 300 مجم 10 كبسولات', '14', '', 'Mucolytic', 'Erdosteine', 'Multi-apex > sobol el dawa misr-egypt', 'Cap', 'كبسولة', '300mg', '1', '', 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', '', '', 1199, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18513, 'Erec 100mg 12 f.c. tablets', 'اريك 100مجم 12 قرص', '144', '100.5', 'Tonic for men', 'Sildenafil', 'Adwia', 'Tablet', 'أقراص', '100mg', '12', 'مقوي للرجال', '', '6223002971404', '', 15961, '2024-05-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'In eliciting its mechanism of action, sildenafil ultimately prevents or minimizes the breakdown of cyclic guanosine monophosphate (cGMP) by inhibiting cGMP specific phosphodiesterase type 5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The result of doing so allows cGMP present in both the penis and pulmonary vasculature to elicit smooth muscle relaxation and vasodilation that subsequently facilitates relief in pulmonary arterial hypertension and the increased flow of blood into the spongy erectile tissue of the penis that consequently allows it to grow in size and become erect and rigid [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].

Interestingly enough, it is precisely via this mechanism why sildenafil was at first researched as a potential treatment for angina - or chest pain associated with inadequate blood flow to the heart - before being serendipitously indicated for treating erectile dysfunction in the late 1980s [A175732]. Nevertheless, it is because of this mechanism that sildenafil is also indicated for treating pulmonary arterial hypertension but is also additionally notorious for interacting with various anti-anginal or anti-hypertensive agents to develop potentially rapid, excessive, and/or fatal hypotensive crises [A175579, A175582, A175654].

Regardless, sildenafil, among a variety of other similar or related PDE5 inhibitors, has become a common and effective treatment for erectile dysfunction and since its formal approval for medical use in the public in 1998 [A175732], continues to see millions of prescriptions written for it internationally. Although the medication has historically been most popularly recognized as Pfizer''s brand name Viagra, sildenafil is currently available generically and even as a non-prescription over the counter medication in some countries [L5656].', '["G01AE10", "G04BE03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18514, 'Erecanova 10 mg 4 disinteg. tabs', 'اريكانوفا 10مجم 4 اقراص سريعة الذوبان', '40', '31', 'Tonic for men', 'Vardenafil', 'Atco pharma > atm pharmaceutical industries', 'Tab', 'أقراص', '10 mg', '1', 'مقوي للرجال', '', '6223002977345', '', 21793, '2023-10-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Vardenafil (Levitra) is an oral therapy for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in turn triggers smooth muscle relaxation, allowing increased blood flow into the penis, resulting in erection. The tissue concentration of cGMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs). The most abundant PDE in the human corpus cavernosum is the cGMPspecific phosphodiesterase type 5 (PDE5); therefore, the inhibition of PDE5 enhances erectile function by increasing the amount of cGMP.', '["G04BE09"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18515, 'Erectalis 20 mg 4 f.c. tab', 'اريكتاليس 20مجم 4 قرص', '148', '100', 'Tonic for men', 'Tadalafil', 'Penta pharma-egypt', 'Tab', 'أقراص', '20 mg', '4', 'مقوي للرجال', '', '6224007738191', '', 2569, '2025-06-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18516, 'Erectalis 20 mg 8 f.c.tabs.', 'ايريكتاليس 20مجم 8 اقراص', '296', '200', 'Tonic for men', 'Tadalafil', 'Penta pharma-egypt', 'Tab', 'أقراص', '20 mg', '8', 'مقوي للرجال', 'about tadalafil a phosphodiesterase 5 enzyme inhibitor treating erectile dysfunction (ed). mechanism of action of tadalafil tadalafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guanosine monophosp', '', '', 1886, '2025-06-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18518, 'Erectawest 100 mg 3 tabs.', 'اريكتاويست 100مجم 3 قرص', '20', '', 'Tonic for men', 'Avanafil', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '100 mg', '1', '', 'avanafil is a pde5 inhibitor approved for erectile dysfunction by the fda on april 27 2012 and by ema on june 21 2013. avanafil is known by the trademark names stendra and spedra and was developed by vivus inc. avanafil acts by inhibiting a specific phosp', '', '', 944, '2022-09-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18519, 'Erectoback 10 mg 30 f.c.tabs.', 'اريكتوباك 10مجم 30 قرص', '188', '', 'Tonic for men', 'Tadalafil', 'October pharma', 'Tab', 'أقراص', '10 mg', '3', 'مقوي للرجال', '', '', '', 1995, '2022-07-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18521, 'Ergoconazol 200 mg 10 f.c.tabs.', 'ارجوكونازول 200مجم 10 اقراص', '700', '', 'Antifungals.triazoles', 'Voriconazole', 'International drug agency > biocapital pharma', 'Tab', 'أقراص', '200 mg', '1', 'مضاد للفطريات', 'indication for the treatment of esophageal candidiasis invasive pulmonary aspergillosis and serious fungal infections caused by scedosporium apiospermum and fusarium spp. mechanism of action voriconazole binds and inhibits ergosterol synthesis by inhibiti', '', '', 2087, '2022-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections.[L15571] It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. The increased affinity of voriconazole for 14-alpha sterol demethylase makes it useful against some [fluconazole]-resistant organisms.[A236050]

Voriconazole was approved by the FDA under the trade name Vfend on May 24, 2002.[L34660]', '["J02AC03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18522, 'Erleada 60 mg 120 tabs.', 'ارليدا 60 مجم 120 قرص', '74,164', '56500', 'Non steroidal antiandrogen', 'Apalutamide', 'Janssen cilag > soficopharm', 'Tab', 'أقراص', '60 mg', '1', '', 'indication (apalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with: *metastatic castration-sensitive prostate cancer (mcspc) *non-metastatic castration-resistant prostate cancer (nmcrpc)', '', '', 998, '2024-09-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Apalutamide is a potent androgen receptor (AR) antagonist that selectively binds to the ligand-binding domain of AR and blocks AR nuclear translocation or binding to androgen response elements [A31846]. It has been used in trials studying the treatment of Prostate Cancer, Hepatic Impairment, Prostatic Neoplasms, Castration-Resistant Prostate Cancer, and Prostatic Neoplasms, Castration-Resistant, among others. Exerting an antitumor action, apalutamide blocking the effect of androgens that promote tumor growth. It targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets in prostate tumors [A31846]. In mice bearing human CRPC xenograft models, apalutamide treatment produced tumor regressions in a dose-dependent manner that was more effective than that of [DB01128] or [DB08899]. Unlike bicalutamide, apalutamide antagonized AR-mediated signaling in AR overexpressing human CRPC cell lines [A31846].

Androgen-deprivation therapy, or hormone therapy, can be used as part of maintenance therapy for patients with non-metastatic prostate cancer. Although most patients achieve therapeutic responses at the initial hormone therapy, many patients progress to non-metastatic castration-resistant (resistance to hormone therapy) prostate cancer which is the second-most common cause of cancer-related deaths in American males [A31852]. Castration-resistant prostate cancer is often incurable, which poses significant clinical challenges for patients. Approximately 10 to 20 % of prostate cancer cases are castration-resistant, and up to 16% of these patients show no evidence of cancer metastasis at the time of castration-resistant diagnosis [L1295]. Higher prostate-specific antigen (PSA) and shorter PSA doubling time (PSA DT) are associated with a higher risk for metastases and death [A31846]. In a phase-2 multicenter open-label study, 89% of patients with non-metastatic, castration-resistant prostate cancer had ≥50% PSA decline at week 12 of apalutamide treatment [A31846]. In a randomized trial, the median metastasis-free survival for patients taking apalutamide was 40.5 months compared to 16.2 months for patients taking a placebo [L1295]. Apalutamide displayed good tolerability and safety profile in clinical studies. 

Apalutamide was approved in February 2018 by the FDA as Erleada for the treatment of patients with non-metastatic prostate cancer that is resistant to treatment with hormone therapy (castration-resistant). It is available as oral tablets. Apalutamide is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer [L1295].', '["L02BB05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18523, 'Erovanafile 100 mg 4 tabs.', 'ايروفانافايل 100 مجم 4 اقراص', '28', '', 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '100 mg', '1', '', 'avanafil is a pde5 inhibitor approved for erectile dysfunction by the fda on april 27 2012 and by ema on june 21 2013. avanafil is known by the trademark names stendra and spedra and was developed by vivus inc. avanafil acts by inhibiting a specific phosp', '', '', 1052, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18524, 'Erovanafile 200mg 4 tabs.', 'ايروفانافيل 200مجم 4 اقراص', '129', '56', 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '200mg', '1', 'مقوي للرجال', '', '', '', 3341, '2025-11-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18525, 'Erovanafile 50mg 4 tabs.', 'ايروفانافايل 50مجم 4 اقراص', '18', '', 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '50mg', '1', '', '', '', '', 914, '2023-02-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18526, 'E-roy 10 caps.', 'اي-روي 10 كبسولات', '56', '', 'Multivitamins', 'Ginseng+royal jelly+wheat germ oil+garlic', 'Sedico', 'Cap', 'كبسولة', '', '1', '', '', '6221042172010', '', 702, '2022-12-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18527, 'Allmed d3 adult oral spray 3000 iu /2spray 21ml', 'اولميد د3 سبراي بالفم للكبار 3000وحدة دولية/2سبراي 21 مل', '300', '', 'Vitamin d', 'Vitamin d', 'Allmed ltd', 'Spray', 'بخاخ', '3000 iu', '1', '', '', '', '', 688, '2023-05-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Vitamin D ultimately comprises a group of lipid-soluble secosteroids responsible for a variety of biological effects, some of which include increasing the intestinal absorption of calcium, magnesium, and phosphate. With reference to human use, there are 2 main forms of vitamin D - vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). When non-specific references are made about ''vitamin d'', the references are usually about the use of vitamin D3 and/or D2.

Vitamin D3 and D2 require hydroxylation in order to become biologically active in the human body. Since vitamin D can be endogenously synthesized in adequate amounts by most mammals exposed to sufficient quantities of sunlight, vitamin D functions like a hormone on vitamin D receptors to regulate calcium in opposition to parathyroid hormone. Vitamin D plays an essential physiological role in maintaining calcium homeostasis and metabolism. There are several different vitamin D supplements that are given to treat or to prevent osteomalacia and rickets, or to meet the daily criteria of vitamin D consumption.', '[]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18528, 'Erythrocin 200 mg/5ml susp. 60ml', 'اريثروسين 200مجم/5مل شراب معلق 60 مل', '8', '', 'Antibiotic.macrolide', 'Erythromycin', 'Kahira > abbott laboratories', 'Susp', 'معلق', '200 mg', '1', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '6221068904510', '', 1037, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18532, 'Erythromycin pharco 200mg/5ml susp. 60ml', 'اريثروميسين فاركو 200مجم/5مل شراب معلق 60 مل', '8', '', 'Antibiotic.macrolide', 'Erythromycin', 'Pharco', 'Susp', 'معلق', '200mg', '1', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '6221151001270', '', 832, '2022-07-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18533, 'Erythromycin stearate 250mg 10 f.c. tabs.', 'اريثروميسين ستيرات 250 مجم 10 اقراص', '7', '', 'Antibiotic.macrolide', 'Erythromycin', 'Hi-pharm', 'Tab', 'أقراص', '250mg', '1', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '', '', 842, '2022-07-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18534, 'Erythromycin stearate 500 mg 8 f.c. tab.', 'اريثروميسين ستيرات 500 مجم 8 اقراص', '8', '', 'Antibiotic.macrolide', 'Erythromycin', 'Hi-pharm', 'Tab', 'أقراص', '500 mg', '2', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '', '', 690, '2022-07-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18536, 'Aaa', 'ششش', '8', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 790, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18537, 'Aaa', 'ششش', '10', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 694, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18538, 'Erytin gel 20 gm', 'ايرتين 20جم جل', '9', '', 'Anti-acne', 'Erythromycin+tretinoin', 'Hikma pharma', 'Gel', 'جل', '20 gm', '1', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '', '', 916, '2022-07-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18539, 'Erytin gel 25 gm', 'اريتين جل 25 جم', '8', '', 'Anti-acne', 'Erythromycin+tretinoin', 'Hikma pharma', 'Gel', 'جل', '25 gm', '1', '', 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '', '', 742, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18541, 'Aaa', 'ششش', '10', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 621, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18542, 'Escita 10 mg 14 f.c.tabs.', 'اسيتا 10مجم 14 قرص', '77', '', 'Psychiatric.antidepressants', 'Escitalopram', 'Genesis pharmaceuticals', 'Tab', 'أقراص', '10 mg', '2', '', 'about escitalopram selective serotonin reuptake inhibitor (ssri) antidepressant. mechanism of action of escitalopram escitalopram is the s enantiomer of racemic citalopram. it is 100 times more potent than r-enantiomer. escitalopram blocks the re-uptake o', '', '', 1609, '2022-10-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18544, 'Escitaloborg 5 mg 10 tablets', 'اسيتالوبورج 5مجم 10 اقراص', '25', '', 'Psychiatric.antidepressants', 'Escitalopram', 'Borg', 'Tablet', 'أقراص', '5 mg', '1', '', '', '', '', 1075, '2022-06-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18546, 'Escitapram 20 mg 20 f.c.tabs.', 'اسيتابرام 20 مجم 20 قرص', '116', '96', 'Psychiatric.antidepressants', 'Escitalopram', 'Sigma > pharma mix-egypt', 'Tab', 'أقراص', '20 mg', '2', '', 'about escitalopram selective serotonin reuptake inhibitor (ssri) antidepressant. mechanism of action of escitalopram escitalopram is the s enantiomer of racemic citalopram. it is 100 times more potent than r-enantiomer. escitalopram blocks the re-uptake o', '6225000352094', '', 1363, '2024-08-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18547, 'Eselinate 250mg 20 tab.', 'ازيلينات 250 مجم 20 قرص', '2', '', 'Systemic haemostatic', 'Ethamsylate', 'Kahira > ravizza', 'Tab', 'أقراص', '250mg', '2', '', 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', '', '', 828, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18548, 'Eselinate 250mg/2ml 2 amp.', 'ازيلينات 250 مجم/2مل 2 امبول', '2', '', 'Systemic haemostatic', 'Ethamsylate', 'Kahira > ravizza', 'Amp', 'أمبول', '250mg', '2', '', 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', '', '', 667, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18549, 'Eslicarba 400 mg 20 tabs.', 'ايسليكاربا 400 مجم 20 قرص', '208', '', 'Anti-epileptic', 'Eslicarbazepine', 'Dbk pharma > genesis pharmaceuticals', 'Tab', 'أقراص', '400 mg', '2', 'يستخدم بمفرده أو مع أدوية أخرى لعلاج نوع معين من اضطرابات الصرع (نوبات بؤرية).فهو يقلل من عدد النوبات.', 'eslicarbazepine is used for: treating partial-onset seizures. it is used along with other medicines. eslicarbazepine is an anticonvulsant. exactly how it works is not known but it may work by slowing abnormal nerve impulses in the brain.', '', '', 1037, '2022-08-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18550, 'Eslizepine 400 mg 20 tabs.', 'ايسليزيبين 400مجم 20 قرص', '342', '262', 'Anti-epileptic', 'Eslicarbazepine', 'Andalous pharma', 'Tab', 'أقراص', '400 mg', '2', 'علاج الصرع __ تقليل نوبات التشنجات', 'eslicarbazepine is used for: treating partial-onset seizures. it is used along with other medicines. eslicarbazepine is an anticonvulsant. exactly how it works is not known but it may work by slowing abnormal nerve impulses in the brain.', '6223004690044', '', 3367, '2024-09-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18551, 'Eslizepine 800mg 20 scored tabs.', 'ايسليزيبين 800مجم 20 قرص', '588', '451', 'Anti-epileptic', 'Eslicarbazepine', 'Andalous pharma', 'Tab', 'أقراص', '800mg', '2', 'علاج المشكلات الصحية والعصبية التالية: علاج الصرع. السيطرة على نوبات الصرع والتقليل من مرات تكرارها. علاج التشنجات العصبية.', '', '6223004690051', '', 2615, '2024-09-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18552, 'Esmatac 20 mg 14 d.r. caps', 'ازماتاك 20مجم دي ار 14 كبسولة', '55', '42', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi', 'Cap', 'كبسولة', '20 mg', '2', 'قرحة المعدة والحموضة', '', '6223003930660', '', 1083, '2023-09-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18553, 'Esmatac 40 mg 28 d.r. caps.', 'ازماتاك 40 مجم دي ار 28 كبسولة', '144', '96', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi', 'Cap', 'كبسولة', '40 mg', '4', 'قرحة معدة وحموضة', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223003930905', '', 2198, '2023-08-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18554, 'Aaa', 'ششش', '41', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 693, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18555, 'Esmopump 20 mg 14 e.c.tabs.', 'ازموبمب 20مجم 14 قرص', '85', '', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Organopharma', 'Tab', 'أقراص', '20 mg', '2', '', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224000908119', '', 1279, '2022-07-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18556, 'Esmopump 40mg 14 f.c. tabs.', 'ايزموبمب 40 مجم 14 قرص', '172', '119', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Organopharma', 'Tab', 'أقراص', '40mg', '2', 'علاج عسر الهضم والتهاب وارتجاع المريء والحموضة المعوية والقضاء على بكتيريا هيليكوباكتر بيلوري (جرثومة المعدة) ومرض القرحة المعدية', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224000908102', '', 5862, '2024-09-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18557, 'Esmorap 10 mg 7 sachets', 'ازموراب 10 مجم 7 اكياس', '63', '45.5', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '10 mg', '1', '', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '', '', 2375, '2024-10-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18558, 'Esmorap 20 mg 7 sachets', 'ازموراب 20 مجم 7 اكياس', '63', '45.5', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '20 mg', '1', '', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223005464309', '', 1341, '2024-11-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18560, 'Esmorap 40 mg 7 sachets', 'ازموراب 40 مجم 7 اكياس', '105', '56', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '40 mg', '1', '', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223005464316', '', 1074, '2024-11-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18562, 'Esmorap 40mg 28 caps.', 'ازموراب 40 مجم 28 كبسولة', '276', '188', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Multi-apex > aug pharma', 'Cap', 'كبسولة', '40mg', '2', '', '', '6223005460578', '', 1160, '2024-11-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18563, 'Esmorap 40 mg powder for i.v. inf. vial', 'ازموراب 40 مجم بودرة فيال', '86', '60', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'El nile. > aug pharma', 'Vial', 'فيال', '40 mg', '1', '', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '', '', 1466, '2025-06-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18564, 'Esogerdazole 40 mg 14 dr. caps', 'ايزوجيردازول 40 مجم 14 كبسولة', '72', '', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Al rowad pharmaceutical industrial co.', 'Cap', 'كبسولة', '40 mg', '2', '', '', '6224000915193', '', 1440, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');